From
Dr. Alberto Tozzi
Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2026 · 1 min read
In brief
In brief
WHO presents a standardized causality assessment tool to help public health programs distinguish vaccine-related adverse events from coincidental illnesses occurring after immunization. The framework addresses the critical challenge of evaluating serious post-vaccination events in childhood immunization programs globally.
Written by the GCMD Library team from the article.
Serious illnesses or even deaths may rarely occur after childhood vaccinations. Public health programs are faced with great challenges to establish if the events presenting after the administration of a vaccine are due to other conditions, and hence a coincidental presentation, rather than caused by the administered vaccines. Given its priority, the Global Advisory Committee for Vaccine Safety (GA…
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Podcast
Le funzioni e gli usi dell'intelligenza artificiale per la salute
Alberto Tozzi · 14 min · Published Oct 2026
Article
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Alberto Tozzi · Published Oct 2026
Podcast
Data to impact: connecting the future of European pediatrics with Alberto Tozzi
Alberto Tozzi · 20 min · Published Oct 2026
Article
[Obesity and cardiovascular risk in children].
Alberto Tozzi · Published Oct 2026
Article
Towards learning healthcare systems in Italy: opportunities and challenges of AI at point-of-care.
Alberto Tozzi · Published Oct 2026
Article
Methicillin-resistant Staphylococcus aureus nasal colonization in a department of pediatrics: a cross-sectional study.
Alberto Tozzi · Published Oct 2026
